Association of sociodemographic factors and comorbidity with non-receipt of medications for secondary prevention: a cohort study of 12,204 myocardial infarction survivors
Abstract Background Clinical guidelines recommend use of (1) antiplatelet, (2) lipid-lowering, and (3) beta blocker medication, and (4) angiotensin-converting enzyme inhibitor or angiotensin receptor blocker (ACEi/ARB) for secondary prevention following myocardial infarction (MI). This study examine...
Na minha lista:
| Principais autores: | , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
BMC
2025-07-01
|
| Serier: | BMC Medicine |
| Fag: | |
| Online adgang: | https://doi.org/10.1186/s12916-025-04160-5 |
| Tags: |
Ingen Tags, Vær først til at tagge denne postø!
|
